CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,524,294 | -27.4% | 516,002 | +10.8% | 0.00% | 0.0% |
| Q2 2023 | $4,853,532 | +49.9% | 465,790 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $3,238,547 | +148.9% | 464,641 | +115.3% | 0.00% | – |
| Q4 2022 | $1,301,100 | -57.3% | 215,771 | -44.2% | 0.00% | -100.0% |
| Q3 2022 | $3,049,000 | -67.3% | 386,976 | -43.5% | 0.00% | -50.0% |
| Q2 2022 | $9,326,000 | +69.1% | 685,270 | +143.7% | 0.00% | +100.0% |
| Q1 2022 | $5,515,000 | -53.1% | 281,224 | -18.0% | 0.00% | -50.0% |
| Q4 2021 | $11,760,000 | -9.0% | 342,757 | +44.9% | 0.00% | 0.0% |
| Q3 2021 | $12,921,000 | +141.2% | 236,560 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $5,356,000 | +247.1% | 72,893 | +331.9% | 0.00% | – |
| Q1 2021 | $1,543,000 | +65.6% | 16,876 | +46.9% | 0.00% | – |
| Q4 2020 | $932,000 | +189.4% | 11,491 | +66.0% | 0.00% | – |
| Q3 2020 | $322,000 | – | 6,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |